Target/therapies for chronic recurrent erythema nodosum leprosum

A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangaraju, Pugazhenthan, Varthya, Shoban Babu, Venkatesan, Sajitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Potential Pharmacological Targets
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446680/
https://www.ncbi.nlm.nih.gov/pubmed/32874007
http://dx.doi.org/10.4103/ijp.IJP_788_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446680/
https://www.ncbi.nlm.nih.gov/pubmed/32874007
http://dx.doi.org/10.4103/ijp.IJP_788_19

Ejemplares similares